Hap Trading, LLC Lantheus Holdings, Inc. Call Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$51.07 - $68.26 $2.57 Million - $3.44 Million	50,400 New	50,400 $18.8 Million
Q4 2019 Feb 11, 2020	SELL	$18.47 - $24.03 $781,281 - $1.02 Million	-42,300 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$21.01 - $28.94 $888,723 - $1.22 Million	42,300 New	42,300 $43,000

540

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.22B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.